Product NDC: | 63323-617 |
Proprietary Name: | Milrinone Lactate |
Non Proprietary Name: | MILRINONE LACTATE |
Active Ingredient(s): | 1 mg/mL & nbsp; MILRINONE LACTATE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-617 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075936 |
Marketing Category: | ANDA |
Start Marketing Date: | 20020801 |
Package NDC: | 63323-617-10 |
Package Description: | 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-617-10) > 10 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 63323-617-10 |
Proprietary Name | Milrinone Lactate |
Package Description | 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-617-10) > 10 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 63323-617 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | MILRINONE LACTATE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20020801 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | MILRINONE LACTATE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] |